Clinical Trial Update: Efficacy and Safety of Nilotinib in CML-CP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of nilotinib in chronic myeloid leukemia, chronic phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Chronic Myeloid Leukemia, Chronic Phase | Phase 4 | Status: COMPLETED